S

Shanghai MicroPort EP Medtech Co Ltd
SSE:688351

Watchlist Manager
Shanghai MicroPort EP Medtech Co Ltd
SSE:688351
Watchlist
Price: 20.15 CNY 0.85% Market Closed
Market Cap: 9.5B CNY
Have any thoughts about
Shanghai MicroPort EP Medtech Co Ltd?
Write Note
Shanghai MicroPort EP Medtech Co Ltd
/
Balance Sheet
/
Other Long-Term Assets

Shanghai MicroPort EP Medtech Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shanghai MicroPort EP Medtech Co Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai MicroPort EP Medtech Co Ltd
SSE:688351
Other Long-Term Assets
¥11.8m
CAGR 3-Years
62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Other Long-Term Assets
¥61.5m
CAGR 3-Years
67%
CAGR 5-Years
116%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Other Long-Term Assets
¥263.2m
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
31%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Other Long-Term Assets
¥2.1B
CAGR 3-Years
-25%
CAGR 5-Years
22%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Other Long-Term Assets
¥122.6m
CAGR 3-Years
-26%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Other Long-Term Assets
¥541.5m
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai MicroPort EP Medtech Co Ltd
Glance View

Market Cap
9.5B CNY
Industry
Health Care

Shanghai MicroPort EP Medtech Co. Ltd. has carved a distinct niche for itself within the rapidly evolving medical device industry, primarily focusing on electrophysiology. This innovative field deals with diagnosing and treating arrhythmias—irregular heartbeats that affect countless individuals globally. MicroPort EP's flagship products include advanced catheter-based systems and cardiac mapping technologies that physicians utilize to pinpoint and correct these heart rhythm disorders. Their solutions are intricately designed to improve the accuracy and effectiveness of ablation procedures, allowing for non-invasive interventions that can significantly enhance patient outcomes. By capitalizing on the increasing prevalence of cardiovascular ailments and the push towards less invasive medical treatments, the company has positioned itself as a pivotal player in the healthcare sector, gaining a competitive edge with its sophisticated R&D capabilities and product innovation. The company's revenue model revolves around the development, manufacturing, and sales of its proprietary electrophysiology devices. By investing heavily in research and development, MicroPort EP continually advances its product offerings, aiming to stay ahead of its competitors and meet the growing demands of healthcare professionals and patients alike. Sales are driven both domestically, within China's burgeoning healthcare market, and internationally, tapping into the global need for cutting-edge cardiac solutions. The integration of technology and healthcare expertise underscores their commitment to quality and innovation, ensuring a sustainable model as they advance in this niche sector. Ultimately, their financial performance reflects a strategic alignment with health trends and technological progress, allowing them to capture value in a market poised for significant growth.

Intrinsic Value
7.2 CNY
Overvaluation 64%
Intrinsic Value
Price
S
What is Intrinsic Value?

See Also

What is Shanghai MicroPort EP Medtech Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
11.8m CNY

Based on the financial report for Dec 31, 2023, Shanghai MicroPort EP Medtech Co Ltd's Other Long-Term Assets amounts to 11.8m CNY.

What is Shanghai MicroPort EP Medtech Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 3Y
62%

Over the last year, the Other Long-Term Assets growth was 43%. The average annual Other Long-Term Assets growth rates for Shanghai MicroPort EP Medtech Co Ltd have been 62% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.